Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04875520 · ClinicalTrials.gov registry record · NA

Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
1,390
Enrollment target

NCT04875520 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 1,390 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04875520, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
1,390 participants
Enrollment target

Study Summary

The primary goal of this study is to determine the most effective SARS-CoV-2 testing strategy for successful return of in-person school in the under-served communities of St. Louis. Regular screening testing has been recommended by the CDC as an additive mitigation strategy for in-person schools in areas of high community transmission. We will compare the effectiveness and acceptance of two different school-based testing strategies among students and school staff (symptomatic testing only versus weekly surveillance testing plus symptomatic testing), measuring school-based SARS-CoV-2 transmission through a cluster randomized trial.

Interventions

  • OTHER Screening testing strategy
  • OTHER No screening testing strategy

Trial Details

FieldValue
Enrollment Target 1,390 participants
Start Date 2021-05-07
Est. Completion 2023-12-31
Phase NA

What the Registry Record Tells You About NCT04875520

The ClinicalTrials.gov registry entry for NCT04875520 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,390 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Screening testing strategy is the first listed.

NCT04875520 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04875520 about?

NCT04875520 is a clinical study titled "Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population". The primary goal of this study is to determine the most effective SARS-CoV-2 testing strategy for successful return of in-person school in the under-served communities of St. Louis. Regular screening testing has been recommended by the CDC as an additive mitigation strategy for in-person schools in...

What is the current status of trial NCT04875520?

This trial is currently completed. It is a NA study. The enrollment target is 1,390 participants. The study started on 2021-05-07. Estimated completion is 2023-12-31.

What interventions are being tested in trial NCT04875520?

The interventions under investigation include: Screening testing strategy (OTHER), No screening testing strategy (OTHER).

Who is sponsoring clinical trial NCT04875520?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.